Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

gavi

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image
By Nigeria Health Watch | August 8, 2024

Nigeria’s Vaccine Financing: Self-Sufficiency is No Longer a Choice, But a Necessity

Tzar Oluigbo (Lead Writer) In 2021, the Africa Centre for Disease Control and Prevention (CDC) published the Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action, calling for 60% of vaccines required by Africans to be made in Africa by 2040 — which is up to 1.7 billion doses annually. Currently, Africa produces only 0.1% of the […]

Read More
Blog Image 26 Jun

Vaccines are a Modern Day Miracle: Gavi’s Role in Sustaining Life-Saving Access

By Nigeria Health Watch | June 26, 2024

Vivianne Ihekweazu and Alexander Chiejina (Lead Writers) “Thanks to the power of immunisation, the number of childhood deaths from vaccine preventable diseases has fallen by 70% since 2000” — Dr Sania Nishtar, CEO of Gavi, The Vaccine Alliance at the Global Forum for Vaccine Sovereignty and Innovation The exponential benefits of vaccines cannot be underestimated. As Chris […]

Read More
Blog Image 18 Apr

Gavi and UNICEF welcome approval of new oral cholera vaccine

By Nigeria Health Watch | April 18, 2024

Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification and can be made available to countries around the world. The prequalification of this new product will help EuBiologics, the manufacturer, produce more volumes of vaccine, faster, and at a lower cost – […]

Read More
Blog Image 4 Apr

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

By Nigeria Health Watch | April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine.• Lassa fever is a deadly hemorrhagic fever common to West Africa. […]

Read More
Blog Image 25 Dec

When Gavi came to visit Nigeria

By Nigeria Health Watch | December 25, 2019

A welcome visit from Gavi As 2019 wound down to its close and holiday plans were being made, arrangements were also being made for a high-level visit of Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance and his team to Nigeria. This was a much-welcomed visit- as it comes after a dark period that saw […]

Read More